Meningococcal B disease: assessment and management
Intended for healthcare professionals

Nursing Standard

CPD Previous     Next

Meningococcal B disease: assessment and management

Adrienne Willcox Nurse director, A Talent 4 Health Limited, Cheltenham
Share to Facebook Share to Twitter Share to Twitter Share to Twitter More...

Serogroup B meningococcal disease is the last main cause of bacterial meningitis and septicaemia in the UK. There is currently no vaccine against this serogroup. This article outlines the nature of meningococcal disease and highlights recent guidance from the National Institute for Health and Clinical Excellence on recognising and managing the disease in primary and secondary care. An update on progress towards a preventive vaccine is also discussed.

Nursing Standard. 26, 26, 50-55. doi: 10.7748/ns2012.02.26.26.50.c8971

Peer review

This article has been subject to double blind peer review

Keywords :

Meningococcal B disease - meningococcal vaccination and immunization - septicaemia

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now

Are you a student? Our student subscription has content especially for you.
Find out more

Organisational access
Read this article via your institutional log in or pair token
Don’t have access via your organisation? Recommend to your librarian

29 February 2012 / Vol 26 issue 26

TABLE OF CONTENTS

DIGITAL EDITION

SUBSCRIBE

Journals